Cargando…

A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study

BACKGROUND: 5–10% of patients are diagnosed with metastatic breast cancer (MBC) at the initial diagnosis. This study aimed to develop a nomogram to predict the overall survival (OS) of these patients. METHODS: de novo MBC patients diagnosed in 2010–2016 were identified from the Surveillance, Epidemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Wen, Wu, Lei, Zhao, Andi, Zhang, Mi, Tian, Qi, Shen, Yanwei, Wang, Fan, Wang, Biyuan, Wang, Le, Chen, Ling, Zhao, Xiaoai, Dong, Danfeng, Zhang, Lingxiao, Yang, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549197/ https://www.ncbi.nlm.nih.gov/pubmed/33046035 http://dx.doi.org/10.1186/s12885-020-07449-1

Ejemplares similares

Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study
por: Zhang, Mi, et al.
Publicado: (2021)

Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database
por: Li, Shuting, et al.
Publicado: (2019)

The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis
por: Zhao, Wen, et al.
Publicado: (2020)

Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database
por: Qiu, Ruiyue, et al.
Publicado: (2019)

Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma
por: Chen, Zheling, et al.
Publicado: (2017)

The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012
por: Yang, Jiao, et al.
Publicado: (2017)

Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits
por: Wang, Biyuan, et al.
Publicado: (2021)

Real-world data of pyrotinib-based therapy for patients with brain metastases of HER2-positive advanced breast cancer: a single-center retrospective analysis and molecular portraits
por: Wang, Hui, et al.
Publicado: (2023)

Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer
por: Shen, Yanwei, et al.
Publicado: (2017)

Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer
por: Chen, Mao-Shan, et al.
Publicado: (2022)

Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment
por: Liang, Wenhua, et al.
Publicado: (2016)

Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy
por: Gou, Miaomiao, et al.
Publicado: (2022)

Nomogram for predicting survival of patients with metastatic nonfunctioning pancreatic neuroendocrine tumors: A SEER based study
por: Ge, Lina, et al.
Publicado: (2021)

Novel Nomograms Individually Predicting Overall Survival of Non-metastatic Colon Cancer Patients
por: Pei, Jun-Peng, et al.
Publicado: (2020)

Development and Validation of Novel Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Patients With Soft Tissue Sarcoma
por: Tu, QiHao, et al.
Publicado: (2021)

Regional location of lymph node metastases predicts survival in patients with de novo metastatic prostate cancer
por: Wang, Zhi-Peng, et al.
Publicado: (2022)

A novel nomogram based on log odds of positive lymph nodes to predict survival for non-metastatic gallbladder adenocarcinoma after surgery
por: Jiang, Shitao, et al.
Publicado: (2022)

Prognostic Nomogram for Disease-Specific Survival in Patients with Non-metastatic Ampullary Carcinoma After Surgery
por: Li, Huang-bao, et al.
Publicado: (2019)

An effective tool for predicting survival in breast cancer patients with de novo lung metastasis: Nomograms constructed based on SEER
por: Wang, WenYi, et al.
Publicado: (2023)

Development and Validation of a Nomogram for Predicting Survival in Patients with Advanced Pancreatic Ductal Adenocarcinoma
por: Deng, Qing-Long, et al.
Publicado: (2017)

Anlotinib plus camrelizumab achieved long‐term survival in a patient with metastatic esophageal neuroendocrine carcinoma
por: Zhou, Lingxiao, et al.
Publicado: (2023)

Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study
por: Wang, Keyi, et al.
Publicado: (2021)

Combined detection of the expression of Nm23-H1 and p53 is correlated with survival rates of patients with stage II and III colorectal cancer
por: Wu, Yinying, et al.
Publicado: (2017)

Nomograms for predicting long-term survival in patients with non-metastatic nasopharyngeal carcinoma in an endemic area
por: Zeng, Qi, et al.
Publicado: (2016)

The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma
por: Zhang, Xiaodi, et al.
Publicado: (2021)

Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma
por: Zheng, Wenwen, et al.
Publicado: (2020)

Postoperative survival analysis and prognostic nomogram model for patients with portal hypertension
por: Zhang, Ya-Fei, et al.
Publicado: (2018)

Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer
por: Goldstein, David, et al.
Publicado: (2020)

Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer
por: Deng, G. C., et al.
Publicado: (2021)

Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer
por: Jiang, Huihong, et al.
Publicado: (2017)

Conditional Survival in de novo Metastatic Urothelial Carcinoma
por: Pal, Sumanta Kumar, et al.
Publicado: (2015)

Nomogram to predict overall survival for patients with non-metastatic cervical esophageal cancer: a SEER-based population study
por: Dong, Dezuo, et al.
Publicado: (2020)

Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area
por: Yao, Ji-Jin, et al.
Publicado: (2021)

Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort
por: Wang, Qing, et al.
Publicado: (2022)

Intraductal papillary carcinoma of breast with invasion: A nomogram and survival from the analysis of the SEER database
por: Liu, Chenguang, et al.
Publicado: (2022)

Development of nomogram and discussion of radiotherapy effect for osteosarcoma survival
por: Xue, Wu, et al.
Publicado: (2023)

Primary tumor resection and lymph node dissection improve survival in de novo metastatic pancreatic ductal adenocarcinoma: an inverse probability of treatment weighting analysis
por: Wu, Chaorui, et al.
Publicado: (2020)

A Novel Nomogram Based on Log Odds of Metastatic Lymph Nodes to Predict Overall Survival in Patients With Perihilar Cholangiocarcinoma After Surgery
por: Zou, Wenbo, et al.
Publicado: (2021)

Correction: Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer
por: Jiang, Huihong, et al.
Publicado: (2018)

Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_afuflq6a4v2u3obou1ssq58hb8